At present, the main treatment for allergic diseases is still based on antihistamines, glucocorticoids, leukotriene receptor antagonists, or anti-IgE monoclonal antibodies (Linton et al., 2023; Kumar and Deshmukh, 2024). Here, IGHE is linked to allergic disease.